Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With Cardiomyopathy
Clinical trial NCT05505838 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT05505838
- Sponsor
- Alnylam Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.